Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ciwujia Capsules + Compound Ciwujia Granules is a combination of Traditional Chinese Medicine (TCM) products primarily derived from *Eleutherococcus senticosus* (Siberian Ginseng). These formulations are traditionally used in China to tonify the kidney, strengthen the spleen, and calm the mind (Anshen). The compound version typically incorporates *Schisandra chinensis* (Wuweizi) to enhance its sedative and adaptogenic properties. This combination is widely utilized for the treatment of insomnia, neurasthenia, and physical exhaustion. It is currently being evaluated in a large-scale, multicenter, prospective real-world study (NCT05813301) involving 40,000 patients to assess its efficacy in improving sleep quality and reducing the consumption of conventional sedative-hypnotic medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ciwujia capsules + compound ciwujia granules.